Malaysia and Taiwan are expecting deliveries of AstraZeneca (AZN.L) COVID-19 vaccines manufactured in Thailand to be delayed, officials said this week, the latest countries to report a holdup with orders from the Thai plant.
The delay comes amid concerns over AstraZeneca’s distribution plans in Southeast Asia, which depends on 200 million doses made by Siam Bioscience, a company …